💥 Fed cuts sparks mid cap boom! ProPicks AI scores with 4 stocks +23% each. Get October’s update first.Pick Stocks with AI

Morning catch up: Market turns as bulls drive higher; S&P500 notches best day since 2022

Published 09/08/2024, 09:20 am
Updated 09/08/2024, 10:00 am
© Reuters.  Morning catch up: Market turns as bulls drive higher; S&P500 notches best day since 2022

It’s days like these the image of Sisyphus endlessly pushing his boulder up the hill come to mind.

Mercurial as always, market sentiment has shifted once again, lifting US markets and smoothing a promising runway for the ASX’s performance today.

ASXFutures are up 1.1% or 85 points as of 8:30am AEST – with a host of company earnings reports expected in the next few hours, plus consumer and producer prices data out of China, it could be another rollercoaster of a day.

US and European markets

The S&P500 had its best day since November 2022, riding chip making shares higher alongside a strong showing in other major tech stocks.

Broadcom (NASDAQ:AVGO) Inc (NASDAQ:AVGO, ETR:1YD) added 6.95%, Intel Corp (NASDAQ:INTC, ETR:INL) 7.90% and Nvidia 6.13%. Meta also climbed 4.2% and Apple (NASDAQ:AAPL) notched a 1.7% uptick.

Zepbound weight loss drug manufacturer Eli Lilly (NYSE:LLY) jumped 9.5% after raising its sales for the year, earning US$1 billion from Zepbound alone.

Popular sportswear brand Under Armour stock surged 19.2% after surprising analysts with a first quarter profit, having successfully cut costs and increased revenue by cutting inventory and promotions.

The Dow Jones lifted 1.8% or 683 points, the S&P500 2.3% and the Nasdaq 464 points or 2.9%.

In Europe, markets were less exuberant. Healthcare stocks lifted the bourses with a 1% bump, driven up by gains by British drugmaker Hikma Pharmaceuticals, which lifted 8.3% on positive annual forecasts.

Novo Nordisk (CSE:NOVOb) (NYSE:NVO) recovered some of its losses from earlier in the week, lifting 4.3%, benefiting from Eli Lilly’s strong numbers.

The FTSE300 posted a 0.1% gain, but major UK stocks like AstraZeneca (NASDAQ:AZN) (-0.49%) and Standard Chartered (LON:STAN) (-2.44%) trading ex-dividend drove the FTSE100 down 0.3%.

Currencies and commodities

The Aussie dollar strengthened against the US dollar overnight, lifting from US$0.6542 to near US$0.6590 at close. The Euro and Japanese Yen went in the other direction; the Euro fell from US$1.0944 to near US$1.0920 and the Yen from JPY145.63 per US dollar to near JPY147.20 at US close.

Oil rose for a third day. Brent crude lifted by US$0.83, or 1.1%, to US$79.16 per barrel and US Nymex by US$0.96, or 1.3%, to US$76.19 per barrel.

Base metals were mixed.

Expectations of higher consumption of copper in China pushed futures up 0.2%, but declining steelmaking production at the industrial city of Tangshan pushed iron ore down US$0.96, or 0.9%, to US$100.75 per tonne and aluminium futures fell 0.5%.

Gold recovered its upward momentum after a wobbly couple of days, up US$30.90, or 1.3%, to US$2,463.30 per ounce and spot gold was trading near US$2,425 per ounce at the market close.

On the small cap front

The ASX Small Ordinaries fell a full 31.8 points or 1.09% yesterday, following the ASX200 down as it shed 0.34% on weak mining and real estate stocks.

You can read about the following and more throughout the day on our website.

  • Lithium Energy Ltd (ASX:LEL) has received shareholder approval for the sale of its Solaroz Lithium Brine Project, which the company intends to offload to a subsidiary of CNGR Advanced Material Co. Ltd for a total consideration of US$63 million.
  • Piedmont Lithium (ASX:NASDAQ:PLL, OTC:PLLTL) Inc achieved quarterly records in terms of lithium production, recoveries, and mill utilisation percentage, having generated about A$13.2 million in revenue from sales of 14,000 dry metric tonnes of spodumene concentrate.
  • Read more on Proactive Investors AU

    Disclaimer

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.